logo

For the Inventor, By the Inventor

Osaka, Japan

Fumiya Ikarashi

This inventor holds 8 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignee: Shionogi Company Limited. Active years: 2016-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fumiya Ikarashi. Retrieved from https://idiyas.com/inventor/fumiya-ikarashi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 11(Granted Patents)


Location History:

  • Osaka, JP (2016 - 2018)
  • Hyogo, JP (2018)

Company Filing History:

goldMedal8 out of 1,001 
 
Shionogi Company Limited
 patents

Years Active: 2016-2018

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents
1. 10125147 - Crystalline methyl (4R,12aS)-7-(benzyloxy)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylate (2018-11-13),
2. 10125146 - Crystalline methyl (4R,12aS)-7-(benzyloxy)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylate (2018-11-13),
3. 10000508 - Crystalline dimethyl 3-(benzyloxy)-1-(2,2-dimethoxyethyl)-4-oxo-1,4-dihydropyridine-2,5-dicarboxylate (2018-06-19),
4. 9969750 - Method of producing (3S,11aR)-6,8-dihalo-3-methyl-2,3,11,11a-tetrahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-5,7-diones (2018-05-15),
5. 9951051 - Process for producing alkynylketone derivative (2018-04-24),
6. 9802959 - Method of producing (4R,12aS)-7,9-dihalo-4-methyl-3,4,12,12a-tetrahydro-2H-pyrido[1',2′:4,5]pyrazino[2,1-b][1,3]oxazine-6,8-diones (2017-10-31),
7. 9650394 - Methods of producing substituted (3S,11aR)-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-Hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamides (2017-05-16),
8. 9321789 - Methods of producing substituted (4R,12AS)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12A-hexahydro-2H-pyrido[1',2′:4,5]pyrazino[2,1-B][1,3]oxazine-9-carboxamides (2016-04-26),

Title: Fumiya Ikarashi – Innovator in Pharmaceutical Chemistry

Introduction

Fumiya Ikarashi, based in Osaka, Japan, is a distinguished inventor recognized for his significant contributions to the field of pharmaceutical chemistry. With a total of eight patents to his name, Ikarashi has established himself as a noteworthy figure in innovation.

Latest Patents

His latest patents include innovative compounds and processes, such as the crystalline methyl (4R,12aS)-7-(benzyloxy)-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylate. This compound showcases a remarkable chemical structure that contributes to advancing medication efficacy. Additionally, he has developed a process for preparing this compound and its derivatives, highlighting his expertise in synthesizing complex organic molecules.

Career Highlights

Fumiya Ikarashi is currently employed at Shionogi & Company Limited, a prominent pharmaceutical company. His role at the company involves extensive research and development, focusing on creating innovative solutions for medical challenges. His portfolio reflects a commitment to pushing the boundaries of pharmaceutical science.

Collaborations

Throughout his career, Ikarashi has collaborated with notable colleagues such as Kazuya Okamoto and Yukihito Sumino. These partnerships have fostered a creative environment that encourages innovative thought and problem-solving in their shared pursuit of developing valuable pharmaceutical products.

Conclusion

Fumiya Ikarashi's contributions to the field of pharmaceutical chemistry, marked by his impressive number of patents and collaborative spirit, underscore his position as a prominent inventor. His work continues to make a significant impact on the industry, paving the way for future innovations in medication development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…